Search

everythinglearnresearchcommunity

for

Search:↓

Men with early-onset hair loss have less cardiometabolic benefit from bromocriptine.

Finasteride helps induce ovulation in nonresponder PCOS women.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

Higher DHEA-S levels are linked to smaller ovarian volume in women with PCOS.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Ethosomes improve drug delivery through the skin and show promise for treating male pattern baldness.

Low-dose oral minoxidil is effective and safe for hair loss, but more research is needed.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

The three-layer microneedle system effectively delivers minoxidil into the skin, showing potential as a safe and efficient treatment for hair loss.

A woman developed thick gums from everolimus treatment after a kidney transplant.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

The FDA rejected a testosterone drug again due to safety concerns.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

The steroid solution can regrow hair but often causes skin issues and doesn't work long-term.

Melatonin improved mental health and metabolism in women with PCOS.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

Minipulse therapy with betamethasone effectively promotes hair regrowth in alopecia areata with fewer side effects.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

Steroid cell tumors in ovaries are rare, can cause hormone changes, and may be cancerous.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

The inhibitor affects androgen metabolism but not ovarian function.

High-dose oral minoxidil in children can cause increased hair growth, especially on the face.

Melatonin may improve some hormonal and inflammatory issues in women with PCOS.

Ovarian hyperthecosis caused high testosterone and virilization symptoms in a 60-year-old woman, which improved after surgery.